International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.
Regulatory requirements to control the level of anti-D in intravenous immunoglobulin (IVIG) products with European and United States (US) licences are to be introduced. A reference preparation of IVIG containing anti-D at 0.0475 IU/ml and having a nominal titre of 8 using the proposed direct haemagglutination reference method was deemed suitable to define the anti-D limit. This preparation, code 02/228, and a negative control IVIG preparation, code 02/226, were established by the World Health Organization as International Reference Reagents (IRRs). As stocks of the IRRs are limited, new larger fill stocks of positive and negative reference preparations, codes 04/132 and 04/140, respectively, were produced. The results from an international collaborative study involving 16 laboratories showed that preparations 04/132 and 04/140 are indistinguishable from the corresponding IRRs 02/228 and 02/226, respectively, using the proposed direct haemagglutination reference method. Stocks of 04/132 and 04/140 have been shared with the European Directorate for the Quality of Medicines (re-coded as 23613 and 23614, respectively) and with the Center for Biologics Evaluation and Research of the United States Food and Drug Administration (re-coded as CBER Lots 1B and 1N-b, respectively) for use as European and US Biological Reference Preparations, respectively.
Thorpe
Susan J
SJ
National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK. sthorpe@nibsc.ac.uk
Fox
Bernard
B
Heath
Alan
A
Behr-Gross
Marie-Emmanuelle
ME
Virata
Maria L
ML
Yu
Mei-Ying W
MY
D005060:Europe; D005069:Evaluation Studies as Topic; D006386:Hemagglutination Tests; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000592:standards*; D007391:International Cooperation; D007518:Isoantibodies / Q000032:analysis*; D012015:Reference Standards; D018029:Rho(D) Immune Globulin; D014481:United States; D014486:United States Food and Drug Administration; D014944:World Health Organization
D016756:Immunoglobulins, Intravenous; D007518:Isoantibodies; C061961:RHO(D) antibody; D018029:Rho(D) Immune Globulin